Results 21 to 30 of about 1,633 (196)

Second annual report from the ISSPP PIPAC database [PDF]

Pleura and Peritoneum, 2023
To monitor the results of PIPAC directed therapy based on data from the International Society for the Study of the Pleura and Peritoneum (ISSPP) PIPAC database.
Mortensen Michael Bau, Casella Francesco, Düzgün Özgül, Glehen Olivier, Hewett Peter, Hübner Martin, Jørgensen Magnus Skov, Königsrainer Alfred, Marin Miguel, Pocard Marc, Rezniczek Günther, So Jimmy, Fristrup Claus Wilki   +12 more
doaj   +5 more sources

Descriptive review of current practices and prognostic factors in patients with ovarian cancer treated by pressurized intraperitoneal aerosol chemotherapy (PIPAC): a multicentric, retrospective, cohort of 234 patients [PDF]

Frontiers in Oncology, 2023
IntroductionOvarian cancer (OC) is the primary cause of mortality in women diagnosed with gynecological cancer. Our study assessed pressurized intraperitoneal aerosol chemotherapy (PIPAC) as treatment for peritoneal surface metastases (PSM) from ...
Amaniel Kefleyesus, Amaniel Kefleyesus, Aditi Bhatt, Cecilia Escayola, Vladimir Khomyakov, Martin Hübner, Marc A. Reymond, René Thieme, Olivia Sgarbura, Wouter Willaert, Wim Ceelen, Wim Ceelen, Andrea Di Giorgio, Giuseppe Vizzielli, Olivier Glehen, Manuela Robella, Naoual Bakrin   +16 more
doaj   +2 more sources

Bidirectional treatment of peritoneal metastasis with Pressurized IntraPeritoneal Aerosol Chemotherapy (PIPAC) and systemic chemotherapy: a systematic review [PDF]

BMC Cancer, 2020
Background Pressurized intraperitoneal aerosol chemotherapy (PIPAC) is used in the palliative treatment of peritoneal metastasis. The combination of intraperitoneal and systemic chemotherapy seems rational, and the aim of this systematic review was to ...
Magnus Ploug, Martin Graversen, Per Pfeiffer, Michael Bau Mortensen   +3 more
doaj   +2 more sources

UK trial of pressurised intraperitoneal aerosolised chemotherapy (PIPAC) with oxaliplatin for colorectal cancer peritoneal metastases (NCT03868228)

Pleura and Peritoneum, 2023
This is the first UK trial of pressurised intraperitoneal aerosolised chemotherapy (PIPAC) for colorectal cancer peritoneal metastases. This trial aimed to assess the impact of PIPAC in combination with standard of care systemic treatment on: progression
Kyle Peter, Perry Kitrick, Moutadjer Anne, Gilfillan Nicholas, Webb Rosalind, Basak Dolan, Ziprin Paul, Blunt Dominic, Burn James, Van Ree Katherine, Sergot Antoni, Murphy Jamie   +11 more
doaj   +2 more sources

Pressurised intraperitoneal aerosol chemotherapy (PIPAC): the first Australian experience

Pleura and Peritoneum
Pressurised intraperitoneal aerosol chemotherapy (PIPAC) is a novel surgical technique for patients with peritoneal metastases not amenable to curative treatment.
Foley Katarina, Reid Jessica, Edwards Suzanne, Price Timothy, Zimet Allan, Woods Susan, Trochsler Markus, Lynch Andrew Craig, Hewett Peter   +8 more
doaj   +3 more sources

Systemic Chemotherapy Including Ramucirumab in Combination With Pressurized Intra-Peritoneal Aerosol Chemotherapy Is a Safe Treatment Option for Peritoneal Metastasis of Gastric Cancer

Frontiers in Oncology, 2021
BackgroundPressurized intraperitoneal aerosol chemotherapy (PIPAC) is a laparoscopic technique for local chemotherapy. It has been used for treatment of peritoneal metastasis of gastric cancer (PM GC) in combination with systemic therapy.
Linda Feldbrügge, Felix Gronau, Andreas Brandl, Andreas Brandl, Timo Alexander Auer, Alan Oeff, Peter Thuss-Patience, Johann Pratschke, Beate Rau   +8 more
doaj   +1 more source

Time‐varying prognostic value of primary tumor sidedness in metastatic colorectal cancer: A population‐based study and meta‐analysis

International Journal of Cancer, Volume 152, Issue 7, Page 1360-1369, 1 April 2023., 2023
What's new? In colorectal cancer (CRC), sidedness is linked to prognosis, with left‐sided primary tumors associated with improved prognosis compared to right‐sided tumors. These associations suggest that sidedness is a potential stratification factor in clinical trials.
Dave E. W. van der Kruijssen, Auke J. S. van der Kuil, Geraldine R. Vink, Cornelis J. A. Punt, Johannes H. W. de Wilt, Sjoerd G. Elias, Miriam Koopman   +6 more
wiley   +1 more source

Assessment of Treatment Response after Pressurized Intra-Peritoneal Aerosol Chemotherapy (PIPAC) for Appendiceal Peritoneal Metastases

, 2022
Background The aim of this study was to analyse survival and surrogates for oncological response after PIPAC for appendiceal tumours. Methods This retrospective cohort study included consecutive patients with appendiceal peritoneal metastases (PM ...
SP Somashekhar, Julio Abba, Ramya G. Rao, Rao, Ramya G., Hugo Teixeira Farinha, Mohammad Alyami, Martin Hübner, Wouter Willaert, Sgarbura, O., Sgarbura, Olivia, Teixeira Farinha, H., Rao, R.G., Alyami, Mohammad, Somashekhar, S.P., Teixeira Farinha, Hugo, Abba, J., Willaert, W., Alyami, M., Olivia Sgarbura, Study Grp, PIPAC, Hübner, M., Abba, Julio, Willaert, Wouter, Hübner, Martin, Somashekhar, SP   +24 more
core   +1 more source

Gastric and gastroesophageal junction cancer: Risk factors and prophylactic treatments for prevention of peritoneal recurrence after curative intent surgery

Annals of Gastroenterological Surgery, Volume 6, Issue 4, Page 474-485, July 2022., 2022
Peritoneal recurrence after curative treatment for gastric cancer is common and has a dismal prognosis. This review summarizes existing knowledge about risk factors for developing peritoneal recurrence and prophylactic treatments to prevent peritoneal recurrence.
Biying Huang, Ioannis Rouvelas, Magnus Nilsson   +2 more
wiley   +1 more source

Synopsis of a clinical practice guideline for pancreatic ductal adenocarcinoma with peritoneal dissemination in Japan; Japan Peritoneal Malignancy Study Group

Journal of Hepato-Biliary-Pancreatic Sciences, Volume 29, Issue 6, Page 600-608, June 2022., 2022
Abstract Patients with pancreatic ductal adenocarcinoma (PDAC) with peritoneal dissemination have a dismal prognosis because discontinuation of systemic chemotherapy is required for massive ascites or poor performance status. The natural history, diagnosis and treatment of PDAC with peritoneal dissemination have not been fully investigated.
Sohei Satoi, Naminatsu Takahara, Tsutomu Fujii, Hiroyuki Isayama, Suguru Yamada, Yasushi Tsuji, Hideyo Miyato, Hironori Yamaguchi, Tomohisa Yamamoto, Daisuke Hashimoto, So Yamaki, Yousuke Nakai, Kei Saito, Hayato Baba, Toru Watanabe, Shigeto Ishii, Masamichi Hayashi, Keisuke Kurimoto, Hideaki Shimada, Joji Kitayama   +19 more
wiley   +1 more source